CIPROFLOXACIN PHARMACOKINETICS IN PATIENTS WITH CYSTIC-FIBROSIS

被引：36
作者：
BENDER, SW
DALHOFF, A
SHAH, PM
STREHL, R
POSSELT, HG
机构：
[1] BAYER AG,PHARMA RES CTR,D-5600 WUPPERTAL,FED REP GER
[2] ZENTRUM INNEREN MED,D-6000 FRANKFURT 70,FED REP GER
来源：
INFECTION | 1986年 / 14卷 / 01期
关键词：
D O I：
10.1007/BF01644804
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：17 / 21
页数：5
相关论文
共 48 条
[1]   DIFFERENCE IN RENAL HANDLING OF CEFSULODIN BETWEEN PATIENTS WITH CYSTIC-FIBROSIS AND NORMAL SUBJECTS [J].
ARVIDSSON, A ;
ALVAN, G ;
STRANDVIK, B .
ACTA PAEDIATRICA SCANDINAVICA, 1983, 72 (02) :293-294
[2]   INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].
BAUERNFEIND, A ;
PETERMULLER, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115
[3]  
BENDER SW, 1984, 9TH P INT CYST FIBR
[4]  
BENDER SW, 1985, 14TH INT C CHEM KYOT
[5]  
BERGAN T, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1955
[6]  
BERGAN T, 1986, ANTIMICROB AGENTS CH
[7]  
BERGOGNEBEREZIN E, 1985, 14TH INT C CHEM KYOT
[8]  
BLUMER JL, 1985, 14 INT C CHEM KYOT
[9]   CIPROFLOXACIN DISTRIBUTION IN PROSTATIC TISSUE AND FLUID FOLLOWING ORAL-ADMINISTRATION [J].
BOEREMA, JBJ ;
DALHOFF, A ;
DEBRUYNE, FMY .
CHEMOTHERAPY, 1985, 31 (01) :13-18
[10]  
BOEREMA JBJ, 1984, LANCET, V2, P695
12345